Wellness clinics are supplying peptides and anti-ageing injections that aren’t approved, meaning they haven’t been checked for safety or effectiveness.
Articles on TGA
Displaying 1 - 20 of 90 articles
International drug companies are threatening to remove medicines from the market if Australia doesn’t offer them a better price. Here’s what’s at stake.
The psychiatrist used to have to stay with the patient during their entire session. Now they’ll be able to leave the room after administering the drug.
Anxiety, psychosis and paranoia are among adverse events people are reporting after using higher-strength medicinal cannabis, according to a new study.
You can have a severe allergic reaction to this herbal medicine even if you’ve previously taken it without any problems.
Once taboo, injecting is becoming normalised in the beauty industry and on social media. But what do peptide serums actually contain? And do the anti-ageing claims stack up?
Here’s what’s in place to protect supplies in the short term, and the risks of long-term instability.
Among a range of proposed reforms, Australia’s therapeutic goods regulator outlines 3 options for SPF labelling – including removing the numbers altogether.
Put on your legal glasses for a moment. Then take our quick quiz to see if you can spot how this medicinal cannabis website bends the rules.
More people are accessing medicinal cannabis than ever expected, or the health system was designed for. And we’re failing patients.
No wonder consumers are confused about whether sunscreens actually work. Here’s what’s behind the latest news.
Medicinal cannabis scripts are rising and reports of side effects are likely an underestimate. Here’s what we know about the risks.
Medicinal cannabis use has increased rapidly in Australia over recent years. But there’s limited evidence it helps the conditions it’s most commonly prescribed for.
Here’s how a drug gets from an idea into patients’ hands – and why Australians sometimes wait longer to access a new drug than their American cousins.
Long-anticipated changes to how Australians buy paracetamol are on their way in a bid to reduce harms. Here’s what’s changing.
Aggressive and misleading marketing is fuelling demand for medicinal cannabis. Here are some of the ways clinics bend the rules.
Commonly used antihistamines in young children can lead to serious side effects including hyperactivity, aggression and hallucination. But there are safer alternatives.
Several Australians have been hospitalised after consuming ‘mushroom gummies’. This highlights the challenges of regulating products that fall somewhere between a food and a medicine.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
As the virus continues to mutate, COVID vaccines are updated. This brings us to the latest announcement about the new ‘monovalent’ vaccines.
Top contributors
-
Health activist, Medreach Pty Ltd., Bond University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor, School of Law, University of Canberra
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
NHMRC Postgraduate Scholar and Fulbright Alumna in Public Health Policy, Monash University
-
Associate Professor of Law, Bond University
-
Lecturer in Law, Sydney Law School, University of Sydney
-
Adjunct Associate Professor, UNSW
-
Postdoctoral Research Fellow, National Drug and Alcohol Research Centre, UNSW
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Associate Professor of Pharmacology, University of Sydney
-
Pharmacist and PhD Candidate, University of Sydney
-
Research Affiliate, The University of Sydney, University of Sydney
-
Clinical pharmacist and Scientia Associate Professor at the National Drug and Alcohol Research Centre, UNSW
-
Professor - Emerging Technologies (Stem Cells) at The University of Melbourne and Group Leader - Stem Cell Ethics & Policy at the Murdoch Children's Research Institute, The University of Melbourne